Top Markets
Coin of the day
Lepu Biopharma Co., Ltd. Lepu Biopharma Co., Ltd.

Lepu Biopharma Co., Ltd.

2157
Classement en actions #9736
Lepu Biopharma Co., Ltd. operates as a biopharmaceutical enterprise,... Lepu Biopharma Co., Ltd. operates as a biopharmaceutical enterprise, concentrating its efforts on the development of innovative oncology therapies. It maintains a broad pipeline of cancer-fighting products primarily aimed at the Chinese market. The company's therapeutic candidates encompass a range of modalities, including cutting-edge antibody-drug conjugates (ADCs), oncolytic virus treatments, and diverse immunotherapies. Among its immuno-oncology offerings are HX008 (an anti-PD-1 mAb) and LP002 (an anti-PD-L1 mAb). The ADC portfolio features MRG003 (targeting EGFR), MRG002 (targeting HER2), MRG001 (targeting CD20), MRG004A (targeting TF), and CMG901 (targeting CLDN18.2). Additionally, Lepu Biopharma is advancing the oncolytic virus CG0070, along with various combination therapies such as HX008+OH2, LP002+OH2, and HX008+LP002. Founded in 2018, the company is headquartered in Shanghai, China.
Prix de l'action
$0.53025422
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$956.81M
Changement (1 jour)
0.61%
Changement (1 an)
-52.36%
Pays
CN
Échange Lepu Biopharma Co., Ltd. (2157)

Catégorie

Historique du prix de l'action pour Lepu Biopharma Co., Ltd. (2157)
Prix de clôture le plus élevé : $0.55 le 2026-08-01

Prix de clôture le plus bas : $0.91 le 2022-02-01
Historique du prix de l'action de Lepu Biopharma Co., Ltd. de 2022 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -1.52%
2025 95.77%
2024 -22.45%
2023 -56.43%
2022 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH